First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab plus Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

被引：2
|
作者：
Remenar, E. [1 ]
Loevey, J. [2 ]
Koltai, P. [1 ]
Horvath, K. [2 ]
Goedeny, M. [2 ]
Kasler, M. [1 ]
机构：
[1] Natl Inst Oncol Head & Neck Oncol, Budapest, Hungary
[2] Natl Inst Oncol, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72175-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S553 / S553
页数：1
相关论文
共 50 条
  • [1] INDUCTION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND 5-FLUOROURACIL FOLLOWED BY RADIOTHERAPY WITH CETUXIMAB FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Keil, F.
    Selzer, E.
    Berghold, A.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Reinisch, S.
    Anderhuber, W.
    Burian, M.
    Kornek, G. V.
    ANNALS OF ONCOLOGY, 2012, 23 : 340 - 341
  • [2] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    de Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A. K.
    Elsaesser, W.
    Kainz, H.
    Riedl, R.
    Kapp, K.
    Kopp, M.
    Kornek, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 273 - 273
  • [3] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, Felix
    Selzer, Edgar
    Berghold, Andrea
    Reinisch, Sabine
    Kapp, Karin S.
    De Vries, Alexander
    Greil, Richard
    Bachtiary, Barbara
    Tinchon, Christoph
    Anderhuber, Wolfgang
    Burian, Martin
    Kasparek, Anne-Katrin
    Elsaesser, Wolfgang
    Kainz, Herbert
    Riedl, Regina
    Kopp, Michael
    Kornek, Gabriela
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 352 - 359
  • [4] Induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil followed by radiotherapy with Cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A-K
    Elsaesser, W.
    Kainz, H.
    Kopp, M.
    Kornek, G.
    ONKOLOGIE, 2012, 35 : 194 - 194
  • [5] Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    de Vries, Alexander
    Berghold, Andrea
    Riedl, Regina
    Fridrik, Michael A.
    Fuereder, Thorsten
    Burian, Martin
    Greil, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
    Argiris, Athanassios
    Heron, Dwight E.
    Smith, Ryan P.
    Kim, Seungwon
    Gibson, Michael K.
    Lai, Stephen Y.
    Branstetter, Barton F.
    Posluszny, Donna M.
    Wang, Lin
    Seethala, Raja R.
    Dacic, Sanja
    Gooding, William
    Grandis, Jennifer R.
    Johnson, Jonas T.
    Ferris, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5294 - 5300
  • [7] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [8] Feasibility of induction docetaxel, cisplatin, 5-fluorouracil cetuximab (TPF-C) followed by concurrent cetuximab radiotherapy for locally advanced head and neck squamous cell carcinoma
    Charalambakis, Nikolaos
    Kouloulias, Vassilis
    Vaja, Helena
    Pectasides, Dimitrios
    Rampias, Theodoros
    Economopoulos, Theofanis
    Katsaounis, Panagiotis
    Siolos, Spiros
    Bartzi, Valentina
    Perisanidis, Christos
    Laschos, Konstantinos
    Maragoudakis, Pavlos
    Proikas, Konstantinos
    Papadimitriou, Nikolaos
    Papadogeorgakis, Nikolaos
    Georgopoulou, Helen
    Zygogianni, Anna
    Artopoulou, Ioli
    Pappa, Eleni
    Dimitriadis, George
    Psyrri, Amanda
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [9] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [10] Induction chemotherapy with Docetaxel, Cisplatin and Cetuximab results in improved response rates if compared to Docetaxel, Cisplatin and 5-FU for locally advanced or inoperable squamous cell carcinoma of the head and neck: promising results of the Austrian multicentric phase II trial (AGMT)
    Keil, F.
    Hartl, M.
    Altorjai, G.
    Pecherstorfer, M.
    Berghold, A.
    Riedl, R.
    De Vries, A.
    Mayrbaeurl, B.
    Fridrik, M. A.
    Fuereder, T.
    Burian, M.
    Greil, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 56 - 57
12345